News Report | December 22, 2021
Chinook Therapeutics & SanReno Announce Chinese Kidney Disease Treatment Joint Venture
On November 30, 2021, Chinook Therapeutics, Inc. (Chinook) announced it had formed a joint venture called SanReno Therapeutics to develop kidney disease treatments in China. Its partner is an investor syndicate led by Frazier Healthcare Partners and Pivotal bioVenture Partners China. Chinook Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of precision medicines for kidney diseases. SanReno Therapeutics will focus on commercializing therapies in the People’s Republic of China, Hong Kong, Macau, Taiwan, and Singapore (the Territory).
Under the terms of the joint venture, Chinook granted SanReno exclusive rights to develop and commercialize Chinook’s . . .